Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Spectrum & Other Psychotic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07479758
What this trial is testing

Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders

Who this might be right for
Major Depressive Disorder (MDD)SchizophreniaBipolar Disorder+1 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 320
Large-scale testing (Phase 3)Study completedNCT01662648
What this trial is testing

Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Janssen Pharmaceutica 1,117
Not applicableNot Yet RecruitingNCT07702526
What this trial is testing

Eye-Movement Intervention for Cognitive Impairment Across Schizophrenia Spectrum

Who this might be right for
SchizophreniaCognitive ImpairmentClinical High Risk for Psychosis
Shanghai Mental Health Center 160
Not applicableUnknownNCT06799325
What this trial is testing

The Effect of Acceptance and Commitment Therapy Intervention on Caregiver Burden in Caregivers of Schizophrenia Patients

Who this might be right for
Care BurdenSchizophreniaCaregiver Mental Health
Cumhuriyet University 60
Large-scale testing (Phase 3)Study completedNCT00828958
What this trial is testing

Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients.

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 53
Large-scale testing (Phase 3)Study completedNCT03893825
What this trial is testing

Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Teva Branded Pharmaceutical Products R&D, Inc. 336
Not applicableStudy completedNCT01036568
What this trial is testing

Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia

Who this might be right for
SchizophreniaPsychosis
National Institute on Drug Abuse (NIDA) 121
Post-approval studies (Phase 4)Study completedNCT00690235
What this trial is testing

Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderDiabetes+1 more
University of Texas Southwestern Medical Center 33
Not applicableStudy completedNCT02845440
What this trial is testing

Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness

Who this might be right for
Cigarette SmokingSchizophreniaBipolar Disorder+2 more
Massachusetts General Hospital 1,165
Not applicableStudy completedNCT06890208
What this trial is testing

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave

Who this might be right for
Coronary DiseaseMyocardial InfarctionHeart Failure+13 more
Universitätsklinikum Hamburg-Eppendorf 176
Large-scale testing (Phase 3)Looking for participantsNCT04411225
What this trial is testing

Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis

Who this might be right for
Early Psychosis
University of California, San Diego 120
Post-approval studies (Phase 4)Ended earlyNCT00934635
What this trial is testing

A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls

Who this might be right for
Schizophrenia
Janssen-Cilag G.m.b.H 2
Not applicableStudy completedNCT02773108
What this trial is testing

Somatic Comorbidities in Psychiatric Patients

Who this might be right for
SchizophreniaMajor Depression DisorderBipolar Affective Disorder
Sveti Ivan Psychiatric Hospital 1,061
Post-approval studies (Phase 4)Study completedNCT00222833
What this trial is testing

The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia

Who this might be right for
OverweightHyperlipidemiaCardiovascular Diseases
University of Pittsburgh 30
Not applicableLooking for participantsNCT03601026
What this trial is testing

Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use

Who this might be right for
Mental IllnessSchizophreniaBipolar Disorder+3 more
Nova Scotia Health Authority 120
Large-scale testing (Phase 3)Study completedNCT00706654
What this trial is testing

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 937
Not applicableStudy completedNCT04147897
What this trial is testing

Implementing mHealth for Schizophrenia in Community Mental Health Settings

Who this might be right for
Schizophrenia
University of Washington 299
Early research (Phase 1)Study completedNCT05179525
What this trial is testing

Comparative Bioavailability of Risperidone.

Who this might be right for
Schizophrenia
Rovi Pharmaceuticals Laboratories 80
Not applicableStudy completedNCT03379480
What this trial is testing

Study on Examination of Therapeutic Efficacy and Potential Mechanisms of Yoga Treatment in Schizophrenia

Who this might be right for
Schizophrenia
National Institute of Mental Health and Neuro Sciences, India 96
Not applicableStudy completedNCT05304780
What this trial is testing

Needs-tailored Nurse-led Recovery Program for Community-dwelling People With Schizophrenia

Who this might be right for
SchizophreniaRecoveryMedication Adherence
National Taipei University of Nursing and Health Sciences 164
Next Page